Ticker > Company >

Quest Laboratories share price

Quest Laboratories Ltd.

NSE: QUESTLAB SECTOR: Pharmaceuticals & Drugs  2408   7   0

107.65
+2.25 (2.13%)
NSE: Today, 03:47 PM

Price Summary

Today's High

₹ 108

Today's Low

₹ 104

52 Week High

₹ 196.8

52 Week Low

₹ 85.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

176.41 Cr.

Enterprise Value

181.35 Cr.

No. of Shares

1.64 Cr.

P/E

17.48

P/B

2.46

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  43.82

CASH

0.14 Cr.

DEBT

5.08 Cr.

Promoter Holding

65.83 %

EPS (TTM)

₹  6.16

Sales Growth

33.94%

ROE

46.15 %

ROCE

57.48%

Profit Growth

100.08 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year33.94%
3 Year39.58%
5 YearNA

Profit Growth

1 Year100.08%
3 Year148.85%
5 YearNA

ROE%

1 Year46.15%
3 Year46.02%

ROCE %

1 Year57.48%
3 Year53.01%

Debt/Equity

0.1774

Price to Cash Flow

58.54

Interest Cover Ratio

19.9102

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 65.83 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 39.5755934760221% for the Past 3 years.
  • Company has been maintaining healthy ROE of 46.017788300603% over the past 3 years.
  • Company has been maintaining healthy ROCE of 53.0081690372521% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 19.9102.
  • The company has an efficient Cash Conversion Cycle of 1.67249999999999 days.
  • The company has a high promoter holding of 65.83%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.78728005533227.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 30.36 59.48 61.64 82.56
Total Expenditure 28.95 53.02 53.8 67.01
Operating Profit 1.42 6.47 7.84 15.55
Other Income 0.07 0.06 0.23 0.23
Interest 0.31 0.3 0.54 0.76
Depreciation 0.39 0.46 0.55 0.57
Exceptional Items 0 0 0 0
Profit Before Tax 0.79 5.77 6.98 14.45
Tax 0.13 1.66 1.94 4.35
Net Profit 0.66 4.11 5.04 10.09
Adjusted EPS (Rs.) 0.61 3.81 4.68 8.46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 1.08 1.08 1.08 11.94
Total Reserves 4.81 8.91 14.02 16.71
Borrowings 1.15 1.33 1.88 1.23
Other N/C liabilities 0.4 0.53 0.62 0.77
Current liabilities 10.95 22.94 29.35 28.65
Total Liabilities 18.4 34.8 46.94 59.29
Assets
Net Block 5.94 7.38 9.84 10.21
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 0
Investments 0.09 0.09 0.09 0.09
Loans & Advances 0.29 0.5 3.04 7.36
Other N/C Assets 0 0 0 0
Current Assets 12.08 26.84 33.98 41.64
Total Assets 18.4 34.8 46.94 59.29
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.79 5.77 6.98 14.45
Adjustment 0.75 0.74 0.86 1.1
Changes in Assets & Liabilities -0.08 -2.78 -2.17 -8.33
Tax Paid -0.41 -0.27 -1.79 -4.21
Operating Cash Flow 1.05 3.46 3.88 3.01
Investing Cash Flow -1.2 -1.89 -3.82 -5.03
Financing Cash Flow 0.04 -0.41 0 2.04
Net Cash Flow -0.11 1.15 0.06 0.02

Corporate Actions

Investors Details

PARTICULARS Sep 2024%
promoters 65.83
anil kumar sabarwal 62.04
tejaswini sabarwal 2.48
vinayak sabarwal 1.30
PARTICULARS Sep 2024%
investors 34.17
ankush kedia 1.83
caifu investment advisory... 1.14
kamlesh chandulal gandhi 1.24
mayuri shripal vora 1.19
persistent growth fund-va... 3.68
priti kamlesh gandhi 1.22

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Quest Laboratories Stock Price Analysis and Quick Research Report. Is Quest Laboratories an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Quest Laboratories and its performance over the period of time. Quest Laboratories stock price today is Rs 107.65.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Quest Laboratories cash from the operating activity was Rs 3.0132542 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Quest Laboratories has a Debt to Equity ratio of 0.1774 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Quest Laboratories , the EPS growth was 80.8066 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Quest Laboratories has OPM of 18.832357079169 % which is a good sign for profitability.
     
  • ROE: Quest Laboratories have a healthy ROE of 46.1512 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Quest Laboratories is Rs 107.65. One can use valuation calculators of ticker to know if Quest Laboratories share price is undervalued or overvalued.
Last Updated on:
Brief about Quest Laboratories
X